BB Good human data, but mixed outcomes or surrogate markers. How we grade →Randomized controlled trial (placebo) · Adults with type 2 diabetes, 12 weeks
Creatine supplementation does not impair kidney function in type 2 diabetic patients: a randomized, double-blind, placebo-controlled, clinical trial
B Gualano, V de Salles Painelli, H Roschel, R Lugaresi, E Dorea, GG Artioli, et al. European Journal of Applied Physiology. 2011.
- In plain language
- Creatine for 12 weeks with exercise training raised muscle phosphocreatine but did not change measured filtration (51Cr-EDTA), creatinine clearance, urea or urine protein and albumin.
- Limits
- Small, 12 weeks, people with diabetes but without known kidney disease. Funding not stated in the abstract.
- Which of our grades it feeds
- BB Good human data, but mixed outcomes or surrogate markers. How we grade →Science summary: Creatine safety: kidneys, hair loss, water weight, stomach upset and who should check first
- Source
- doi.org/10.1007/s00421-010-1676-3 · PubMed 20976468
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.